Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Inventory Average (2016 - 2025)

Historic Inventory Average for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to $30.2 million.

  • Myriad Genetics' Inventory Average rose 1529.64% to $30.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year increase of 1529.64%. This contributed to the annual value of $24.8 million for FY2024, which is 1757.72% up from last year.
  • As of Q3 2025, Myriad Genetics' Inventory Average stood at $30.2 million, which was up 1529.64% from $28.5 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Inventory Average peaked at $30.2 million during Q3 2025, and registered a low of $15.4 million during Q1 2022.
  • Over the past 5 years, Myriad Genetics' median Inventory Average value was $23.3 million (recorded in 2024), while the average stood at $22.6 million.
  • Its Inventory Average has fluctuated over the past 5 years, first tumbled by 4023.21% in 2022, then surged by 4290.32% in 2023.
  • Quarter analysis of 5 years shows Myriad Genetics' Inventory Average stood at $17.0 million in 2021, then grew by 17.11% to $19.8 million in 2022, then increased by 18.64% to $23.6 million in 2023, then increased by 14.01% to $26.8 million in 2024, then increased by 12.29% to $30.2 million in 2025.
  • Its last three reported values are $30.2 million in Q3 2025, $28.5 million for Q2 2025, and $27.9 million during Q1 2025.